186 related articles for article (PubMed ID: 37650153)
21. Exploration of Different Hypoxia Patterns and Construction of a Hypoxia-Related Gene Prognostic Index in Colorectal Cancer.
Bai S; Chen L; Yan Y; Li R; Zhou Y; Wang X; Kang H; Feng Z; Li G; Zhou S; Drokow EK; Ren J
Front Immunol; 2022; 13():853352. PubMed ID: 35711425
[TBL] [Abstract][Full Text] [Related]
22. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract][Full Text] [Related]
23. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
24. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
25. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
[No Abstract] [Full Text] [Related]
26. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
27. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
28. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
29. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
[TBL] [Abstract][Full Text] [Related]
30. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
[TBL] [Abstract][Full Text] [Related]
31. A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma.
Liang L; Liu L; Mai S; Chen Y
Eur J Med Res; 2023 Jan; 28(1):41. PubMed ID: 36681855
[TBL] [Abstract][Full Text] [Related]
32. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma.
Yuan Q; Zhang W; Shang W
Front Endocrinol (Lausanne); 2022; 13():1045167. PubMed ID: 36518255
[TBL] [Abstract][Full Text] [Related]
34. Construction and verification of a histone deacetylases-related prognostic signature model for colon cancer.
Hao L; Lu W; Wu J; Chen Y; Xu D; Wang P
Sci Rep; 2024 Apr; 14(1):8983. PubMed ID: 38637684
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
Miao YD; Kou ZY; Wang JT; Mi DH
World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
[TBL] [Abstract][Full Text] [Related]
36. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
Jiang C; Liu Y; Wen S; Xu C; Gu L
Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
[TBL] [Abstract][Full Text] [Related]
37. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
[TBL] [Abstract][Full Text] [Related]
38. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
Front Oncol; 2022; 12():941156. PubMed ID: 36505813
[TBL] [Abstract][Full Text] [Related]
39. Construction of a prognostic model based on genes associated with mitochondrial energy metabolic pathway in colon adenocarcinoma and its clinical significance.
Zhang X; Liang C; Zhou B; Pang L
J Mol Recognit; 2023 Aug; 36(8):e3044. PubMed ID: 37322568
[TBL] [Abstract][Full Text] [Related]
40. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma.
Cheng X; Wei Y; Fu Y; Li J; Han L
Front Immunol; 2022; 13():1052182. PubMed ID: 36532007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]